Do national medicinal drug policies and essential drug programs improve drug use?: a review of experiences in developing countries

Ratanawijitrasin, Sauwakon; Soumerai, Stephen B.; Weerasuriya, K

doi:10.1016/s0277-9536(00)00390-7

Cited by 59 publications

(41 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Social, economic, and health dynamics shape patterns in the use of medicines. In developing economies, social class inequalities can have an additional impact on expanding the right to access to medicines and their rational use 2 .…”

Section: Introductionmentioning

confidence: 99%

Patterns in the use of medicines by university students in Maputo, Mozambique

et al. 2007

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Patterns in the use of medicines by university students in Maputo, Mozambique

et al. 2007

View full text Add to dashboard Cite

“…Globally the mounting concerns towards access to affordable medicines have pushed the governments especially in developing economies to develop national policies in order to increase the affordability, supply, safety, and RUM (Ratanawijitrasin et al, 2001). Among nine components of NMP indicated by WHO, two clearly emphasize on affordability and drug financing.…”

Section: National Medicine Policies (Nmps)mentioning

confidence: 99%

Efficacy of international approaches to medicine price regulation and control: A scoping review

et al. 2017

View full text Add to dashboard Cite

Background:The access to affordable medicines is counted as a challenge, despite international measures taken towards cost containment and price regulation. Objective: To identify and review the literature on international approaches related to medicine price regulation, control, and its effectiveness. Methods: In this scoping review, peer-reviewed research and review articles, discussion papers, public documents relating to medicine pricing policies were reviewed. The search strategy was structured according to STARLITE principles. The key search terms and phrases were "medicine prices", "causes of high medicine prices", " approaches towards medicine prices control", "national medicine policies", "international approaches towards medicine price control", "containment policies", and "effects of pricing policy on medicine". Results: Medicine pricing and price regulation policies were drafted and implemented with no optimal results and things don't seem to have improved much and remain as the distant goal. These policies were either less comprehensive, outdated and fell short in implementation especially in low and middle-income countries (LMICs) due to lack of funding, infrastructure or trained professional task force. Overall, none of the policy options was preferred. Multi-pronged policy options crafted in local context are required to tackle the issue. Conclusion: The authors identify gaps in the literature and propose advanced research in the area to strengthen the healthcare system by improving medicine pricing system in each country.

show abstract

“…The FGDOP regulates mainly four aspects of medicines use: safety, quality, efficacy and price. Traditionally, governments in many countries, particularly developed nations have attempted to ensure the efficiency, safety, rational prescribing, and dispensing of drugs through premarketing registration, licensing and other regulatory requirements (Ratanwijitrasin et al, 2001).…”

Section: Medicines Legislation Framework In Sudanmentioning

confidence: 99%

“…Findings from most published studies lack comparable quantitative information that would allow for objective judging whether and by how much progress on the various outcomes have been made by the implementation of the pharmaceutical regulations. To ignore evaluations and to implement drug regulation based on logic and theory is to expose society to untried measures in the same way patients were exposed to untested medicines (Ratanwijitrasin et al, 2001). In Sudan, the researchers did not identify any rigorous evaluations or quantitative studies about the impact of drug regulations on the quality of medicines and how to protect public health against counterfeit or low quality medicines, although it is practically possible.…”

Section: Introductionmentioning

confidence: 99%

Pharmaceuticals in Sudan: Development in regulations, governance and implementation of national drug policies

Ali¹,

Omer²

2012

Afr. J. Pharm. Pharmacol.

View full text Add to dashboard Cite

The strategy of price liberalisation and privatisation had been implemented in Sudan over the last decade, and has had a positive result on government deficit. The investment law approved recently has good statements and rules on the aforementioned strategy in particular to pharmacy regulations. Under the pressure of the new privatisation policy, the government introduced radical changes in the pharmacy regulations. The 2001 Pharmacy and Poisons Act and its provisions established the Federal Pharmacy and Poison Board (FPPB). All the authorities of the implementation of Pharmacy and PoisonsAct were given to this board. This article provides an overview of the impact of the pharmaceutical regulations on the quality of medicines on the Sudanese market from the perspective of the pharmacists working with drug importing companies. The information necessary to conduct the evaluation was collected from 30 pharmacists who are the owners or shareholders in medicines' importing companies. The participants were selected randomly. 89% of respondents considered the medicines on the Sudanese market generally of good quality. The design of the research itself may be considered inadequate with regard to selection process. However, the authors believe it provides enough evidence, and the current pharmaceutical regulations have some loopholes. The Pharmacy, Poisons, Cosmetics and Medical Devices Act-2001 and its regulation should be enforced. The overall set-up including the Act itself needs to be revised.

show abstract

Do national medicinal drug policies and essential drug programs improve drug use?: a review of experiences in developing countries

Cited by 59 publications

References 20 publications

Patterns in the use of medicines by university students in Maputo, Mozambique

Patterns in the use of medicines by university students in Maputo, Mozambique

Efficacy of international approaches to medicine price regulation and control: A scoping review

Pharmaceuticals in Sudan: Development in regulations, governance and implementation of national drug policies

Contact Info

Product

Resources

About